FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a biologically active composition for treating and correcting immune status. Biologically active composition for treating and correcting the immune status, consisting of preserved donor connective tissue with eliminated cell elements, wherein 80–90 % of chemical bonds of proteoglycans and glycoproteins are unlocked, and the composition is lyophilizate for oral administration and contains: hydrolysed collagen, chondroitin sulphate, elastin taken in certain proportions.
EFFECT: composition described above enables higher therapeutic effectiveness of the biologically active composition due to high content of hydrolysed collagen, which provides structuring of water.
3 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING POSTCOVID SYNDROME BY ALLOPLANT BIOMATERIAL | 2021 |
|
RU2760090C1 |
| METHOD FOR INCREASE OF ADAPTATION TO PHYSICAL LOADS AND BODY RESTORATION BY "ALLOPLANT" BIOMATERIAL | 2017 |
|
RU2649135C1 |
| METHOD OF RETROSCLEROFILLING OF EYES WITH DISPERSED BIOMATERIAL "ALLOPLANT" | 2016 |
|
RU2610211C1 |
| METHOD OF TREATING EXUDATIVE OTITIS MEDIA | 2015 |
|
RU2587849C1 |
| METHOD FOR IMMUNODEFICIENT CONDITIONS CORRECTION BY "ALLOPLANT" BIOMATERIAL | 2016 |
|
RU2634631C1 |
| METHOD FOR TREATING EPICONDYLITIS OR HEEL SPURS USING ALLOPLANT BIOMATERIAL | 2015 |
|
RU2577292C1 |
| METHOD OF TREATING DEGENERATIVE AND INFLAMMATORY-DEGENERATIVE ARTHROPATHIES WITH ALLOPLANT BIOMATERIAL | 2015 |
|
RU2574973C1 |
| METHOD FOR TREATING VIRAL HEPATITIS OR LIVER CIRRHOSIS WITH "ALLOPLANT" BIOMATERIAL | 2015 |
|
RU2609252C1 |
| METHOD OF TREATING DORSOPATHY WITH ALLOPLANT BIOMATERIAL | 2015 |
|
RU2577508C1 |
| METHOD OF TREATING GASTRODUODENAL ULCER | 2014 |
|
RU2570343C1 |
